Pioneering regenerative therapies for genetic disease and dermatologic repair

Harnessing the power of the body’s intercellular delivery processes to disrupt the progression of degenerative disease and address the cellular mechanisms associated with skin dysfunction

Precision therapeutics derived from engineered exosomes

Non-viral genetic medicines for diseases of the peripheral nervous system

Fibroblast-derived exosomes offer a scalable nonviral, reprogrammable alternative to traditional viral vector therapies, with potential to reach broad populations in rare diseases.

Regenerative solutions for age-related functional skincare

Precision therapeutics based on fibroblasts, the body's natural source of collagen, elastin, and hyaluronic acid, to repair the extracellular matrix and resolve aging-related skin decline at the cellular level.

Our Goal
Deliver novel therapeutics based on the body's natural intercellular signaling to address persistent unmet needs in genetic disease and advanced functional skincare.

Harnessing the power of exosomes

Neucore’s proprietary Fibroblast-Derived Engineering Extracellular Vesicles (FiXE^™) platform enables unparalleled cell-targeted delivery of genetic therapeutics to address complex diseases and advance the next generation of functional skincare.

The FiXE platform harnesses the unique regenerative biology of fibroblasts—cells central to tissue repair and structural integrity—to engineer exosomes capable of restoring function at the cellular level, offering a cost effective, scalable solution for genetic medicine and dermatology.

Exosomes are nanoscale extracellular vesicles secreted by all cells to facilitate intercellular communication, naturally transporting proteins, lipids, and genetic material, such as RNA, to modulate gene expression and cellular behavior. FiXE enables precise delivery of RNA and other payloads to diseased cells, addressing unmet needs in genetic and degenerative conditions.

Fibroblasts are essential for skin structure, firmness, and repair. FiXE targets aging fibroblasts to stimulate regeneration and rebuild the extracellular matrix—offering a differentiated and safe approach to skin rejuvenation and repair.

The platform enables tunable, cell-specific delivery of genetic cargo with exceptional biocompatibility, low immunogenicity, and the ability to cross biological barriers— making it ideally suited for both regenerative medicine and dermatology applications.